Home Fairfield Westport’s ViralClear opens phase 2 clinical trial for COVID-19 drug FairfieldHealth CareLatest NewsMedicinePremium Content Westport’s ViralClear opens phase 2 clinical trial for COVID-19 drug By Kevin Zimmerman - June 18, 2020 SHARE Facebook Twitter Merimepodib demonstrated decreased viral production of COVID-19 by over 90%, and when combined with Gilead’s remdesivir, to undetectable levels. This content is for Westfair Online members only. Please Sign in / Join to view this content. Become a member by Registering Here.